Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma Clinical Trials in Beijing

Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.